result of parathyroid hormone on bony tissue in some patients with hyperparathyroidism. Multiple brown tumors may simulate malignant disease and it is a real challenge for the clinicians in the differential diagnoses. Brown tumor as the only and initial symptom of normocalcemic primary hyperparathyroidism is a rare clinical entity. Here, we present a case with multiple brown tumors in a young normocalcemic woman as a sequele of primary hyperparathyroidism mimicking bone metastases. Doi : https://doi.org/10.3329/bjnm.v22i1.40515 normocalcemic primary hyperparathyroidism is extremely rare (4). Multiple brown tumors may simulate cancer metastasis and it is a real challenge for the clinicians in the differential diagnoses (5). Although the measurement of serum calcium and parathyroid hormone (PTH) level provides early diagnosis and decreases the incidence of radiologic bone involvement, progressive major bone lesions may still be observed in developing countries. Here, we present a case with multiple brown tumors in a young woman as a sequence of PHPT without accompanying hypercalcemia mimicking bone metastases on radiography.
INTRODUCTION
Brown tumors are a rare clinical consequence of primary hyperparathyroidism (1) . These are non neoplastic lesions resulting from abnormal bone metabolism, localize in areas of intense bone resorption and the bony defect filled with fibroblastic tissue. Brown tumors arise secondary to both primary and secondary hyperparathyroidism and have been reported to occur in 4.5% of patient with primary hyperparathyroidism (PHPT) and 1.5-1.7% of these with secondary hyperparathyroidism (2) . The reported prevalence of the brown tumour is 0.1%. The disease can manifest at any age, but it is more common among person older than 50 years, and is three times more common in woman than in man (3) . Hyperparathyroidism is usually associated with high levels of serum calcium. Brown tumour as the only and initial symptom of Even though, these findings suggested metastatic bone lesions, the levels of tumor markers such as CEA, CA-125 and ALP were all within normal limits. Repeat laboratory studies, however, unveiled the differential diagnosis of metabolic bone disease (brown tumor). Blood counts and routine biochemical analysis were normal except for an A dual phase 99mTc Sestamibi (MIBI) parathyroid SPECT/CT scan showed intense radiotracer uptake in the left upper neck consistent with parathyroid tumor and uptake of 99mTc-MIBI in the left clavicular swelling, ribs and skull bones ( Figure 4 ). Biopsy of the clavicular lesion revealed a dense infiltration of the marrow by a reactive fibroblastic tissue with scattered multinucleated giant cells; hemorrhage and increased osteoblastic activity consistent with brown tumor ( Figure 6 ).There were no malignant cell indicating metastasis. Calcium and vitamin D supplementations were ensured. 
CASE REPORT

DISCUSSION
Brown tumor comprises only a small percentage of bone expanding or osteolytic bony pathologies (6) . It is caused by hyperparathyroidism, which may be primary o, secondary or tertiary. Primary hyperparathyroidism due to parathyroid adenoma is one of the leading causes of Brown tumour. In our case, the increase secretion of PTH from the parathyroid adenoma triggered high osteoclast turnover activity, leading to multiple bone expanding lytic lesions (7) . Initially, radiography, CT and MIBI of multiple osteolytic mass in the ribs, clavicle and humerus suggested that the bone lesions were brown tumor or metastases from a malignant parathyroid tumor. The high level of intact PTH in the serum; and MIBI positive lesions in the neck indicated that the patient might have the primary hyperparathyroidism and multiple bone metastases caused by carcinoma of the parathyroid gland rather than a benign tumor. However, after surgery, the parathyroid tumor was diagnosed as a parathyroid adenoma by histopathology rather than carcinoma. The biopsy from the lesion of left clavicle revealed brown tumor. At one and half years after tumor resection, there has been no recurrence of either the hyperparathyroidism or the metastases. These findings indicate that the patient did not have parathyroid carcinoma. Brown tumors are considered as the advanced stage of complication of HPT and are mainly the first presentation of the disease. They are relatively rare nowadays due to early diagnosis and prompt treatment of HPT. Inspite of this, Dilip et al. reported a series of 40 cases that all had generalized skeletal involvement (8) . Within the skeletal manifestations of hyperparathyroidism are brown tumors that appear in approximately 10% of cases and in advanced stages of the disease. They may appear in any part of skeleton most commonly seen on the ribs, clavicle and pelvis. Involvement of the long bone is considered rarely in patient with primary HPT. Our patient brings the number of long bone brown tumor in primary HPT to a few cases of literature (9) . Only a few cases are occurred with normocalcemic primary HPT.
The tumors are usually soft, painless, minimally tender and appears elastic on palpation (10) . Occasionally the lesions are painful (11) , as was seen in our patient. The tumors are called 'brown' because of its color, which is a result of vascularity, hemorrhage and deposits of hemosiderin (10, 11) . Since the major action of PTH is to raise serum calcium level, the main biochemical abnormality in primary HPT is an increase in the circulating concentrations of both PTH and calcium (12) . Some patients with proven parathyroid adenoma have normal serum calcium level or the hypercalcemia (13) . Approximately 20% of patient with normocalcemic primary hyperparathyroidism are true normocalcemic (12, 13) , as in our case.
The diagnosis of HPT should be established by determination of the serum calcium, phosphate, alkaline phosphatase and PTH level rather than histopathological examination of focal lesion. The main challenge in diagnosing brown tumor is that it can be seen in normocalcemic patient as well (10) , as in our patient. On CT scan brown tumor appears as a lytic lesion with associated soft tissue mass. However the appearance on CT is not specific, and metastases or multiple myeloma may have a similar appearance (14) . Tc-99m MIBI might be taken up by brown tumors along with the parathyroid tumor, mimicking metastatic parathyroid carcinoma (15) . The case reported here and few others reported in literature introduced an important caution in the interpretation of skeletal lesions taken up by Tc-99m MIBI. In patient suspected of harboring parathyroid carcinoma. 
CONCLUSION
Brown tumors are extremely rare in normocalcemic primary hyperparathyroidism. We have reported a case of rarely seen metabolic bone disease mimicking the presentation of bone metastases. The point in reporting this case is that accurate diagnosis enables the proper treatment to be carried out, avoiding unnecessary harm to the patient.
